InvenireX, a Newcastle-based biotech startup, secured £2 million in Seed funding to commercialize its DNA nanotechnology platform that detects disease at the earliest biological stages. The platform uses DNA nanostructures and AI to identify disease markers with greater sensitivity and speed than current methods.
The UK’s next big biotech? InvenireX secures £2M to commercialise its disease detection platform
November 18, 2025